8-KCNSPCIK 0001729427

CNS Pharmaceuticals, Inc.

Name: SEC EDGAR filing 0001683168-26-007552
Creator: CNS Pharmaceuticals, Inc.
License: https://www.usa.gov/government-works

Material event (8-K) filed October 2, 2026.

Current report announcing a material event, such as an acquisition, executive change, or earnings release.

Open the filing on SEC.gov

New to the 8-K? What it is and how to read one

Filing facts

Accession number: 0001683168-26-007552
Filer: CNS Pharmaceuticals, Inc.
Ticker: CNSP
CIK: 0001729427
Form type: 8-K
Form description: Material event
Filed at: October 2, 2026
Industry: SIC 2834Pharmaceutical Preparations
Last verified: October 2, 2026SecFilingDex pulls from EDGAR with daily cadence

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/1729427/000168316826007552/0001683168-26-007552-index.htm ↗

Filer's full EDGAR submission history

EDGAR · CNS Pharmaceuticals, Inc. (0001729427) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001683168-26-007552.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.